← Evidence map

ArticlePloS one2025

Effects of combination therapy of a CDK4/6 and MEK inhibitor in diffuse midline glioma preclinical models.

Yusuke Tomita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 41428766